液体塞栓剤市場規模、成長と動向分析レポート 2025-2033年

世界の液体塞栓剤市場規模は、2024年には2億5,790万米ドルと推定され、2025年から2033年にかけて9.89%のCAGRで成長し、2033年には5億9,500万米ドルに達すると予測されています。液体塞栓剤業界は、主に低侵襲手術の進歩と世界的な血管疾患の罹患率の増加によって推進されています。

医療システムが低侵襲技術へと移行するにつれ、動脈瘤、動静脈奇形（AVM）、腫瘍などの治療に使用される塞栓剤の需要が急増しています。AVM、硬膜動静脈瘻（DAVF）、多血性腫瘍など、神経血管および末梢血管の異常や疾患の増加が、市場の成長を主に牽引しています。国立生物工学情報センター（National Center for Biotechnology Information）が発表した研究論文によると、動静脈奇形（AVM）は、臨床症状が現れるまで約15%の症例で無症状であることが多いとされています。AVMの41%から79%は頭蓋内出血を伴います。AVMは、脳動脈瘤に次いで頭蓋内出血の2番目に多い原因であり、くも膜下出血全体の約10%を占めています。

小児は成人よりも出血を起こす可能性が高くなります。出血は典型的には脳実質内で起こりますが、くも膜下腔で発生することもあります。さらに、Radiopaedia.orgが2024年11月に発表した記事によると、孤立性脳動静脈奇形（AVM）の発生率は98%、多発性脳動静脈奇形（AVM）は2%です。したがって、AVM症例の増加は市場成長の主な要因となっています。

Liquid Embolic Agent Market Summary

The global liquid embolic agent market size was estimated at USD 257.9 million in 2024 and is projected to reach USD 595.0 million by 2033, growing at a CAGR of 9.89% from 2025 to 2033. The liquid embolic agent industry is primarily driven by advancements in minimally invasive procedures and the increasing prevalence of vascular diseases worldwide.

As healthcare systems shift towards less invasive techniques, the demand for embolization agents used in treating conditions like aneurysms, arteriovenous malformations (AVMs), and tumors has surged. The growing neurovascular and peripheral vascular abnormalities and diseases such as AVMs, dural arteriovenous fistulas (DAVFs), and hypervascular tumors, among others are primarily driving the market growth. According to a research article published by the National Center for Biotechnology Information, arteriovenous malformations (AVMs) are often asymptomatic in about 15% of cases until a clinical event occurs. Between 41% and 79% of AVMs are present with intracranial hemorrhage. They are the second most common cause of intracranial bleeding after cerebral aneurysms, accounting for approximately 10% of all subarachnoid hemorrhages.

Children are more likely than adults to be present with hemorrhage. While hemorrhages are typically intraparenchymal, they can also primarily occur in the subarachnoid space. In addition, according to an article published by Radiopaedia.org in November 2024, the incidence of solitary AVM is 98% and multiple AVM is 2%. Thus, growing AVM cases are a primary contributor to market growth.

Furthermore, according to an American Chemical Society report published in April 2021, brain aneurysms are abnormal dilations that primarily develop at the branch points of cerebral blood vessels. Over 60% of aneurysms are now managed using minimally invasive endovascular techniques, such as flow diversion or the permanent placement of metallic intrasaccular coils. However, these current devices have an unfavorable primary success rate in approximately 20-30% of cases, and the overall effectiveness varies significantly depending on the aneurysm’s type and location. Hence, this brings a growth opportunity for the liquid embolic agent industry during the forecast period.

Neurovascular embolization is commonly performed using liquid embolic agents to treat conditions such as AVMs, DAVFs, and hypervascular tumors. Currently, commonly used liquid embolic agents include n-butyl cyanoacrylate (n-BCA) and ethylene vinyl alcohol copolymer (EVOH) based agents, such as Onyx (Medtronic), Squid (Balt), and PHIL (Terumo), a non-biodegradable iodine-based liquid embolic agent. Additionally, TRUFILL (CERENOVUS, Johnson & Johnson) has recently been introduced. For instance, in March 2024, CERENOVUS, a division of Johnson & Johnson MedTech, announced the launch of the TRUFILL n-BCA Liquid Embolic System Procedural Set. This new offer expands CERENOVUS’s hemorrhagic stroke portfolio by providing a comprehensive procedural set that includes two configuration options and all necessary accessories for preparing and delivering the TRUFILL n-BCA Liquid Embolic System. These agents are favored for their ability to effectively occlude abnormal vascular structures, providing minimally invasive treatment options with high precision. The choice of embolic agent depends on the specific clinical scenario and lesion characteristics, with ongoing innovations aiming to improve safety, handling, and long-term efficacy in neurointerventional procedures.

Liquid Embolic Agent Market Report Scope

Global Liquid Embolic Agent Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global liquid embolic agent market report based on product type, application, end use, and region:

• Product Type Outlook (Revenue, USD Million, 2021 – 2033)
• Ethylene Vinyl Alcohol Copolymer (EVOH)
• Cyanoacrylates

o N-BCA (n-Butyl Cyanoacrylate)

o N-HCA (n-Hexyl Cyanoacrylate)

• Others
• Application Outlook (Revenue, USD Million, 2021 – 2033)
• Arteriovenous Malformations (AVM)
• Hypervascular Tumors
• Peripheral Vasculature Hemorrhage
• Others
• End Use Outlook (Revenue, USD Million, 2021 – 2033)
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers (ASCs)
• Others
• Regional Outlook (Revenue, USD Million, 2021 – 2033)
• North America

o U.S.

o Canada

o Mexico

• Europe

o Germany

o UK

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

• Asia Pacific

o Japan

o China

o India

o South Korea

o Australia

o Thailand

• Latin America

o Brazil

o Argentina

• Middle East & Africa

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Table of Contents

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope

1.1.1. Product Type

1.1.2. Application

1.1.3. End-use

1.1.4. Regional scope

1.1.5. Estimates and forecast timeline

1.2. Research Methodology

1.3. Information Procurement

1.3.1. Purchased database

1.3.2. GVR’s internal database

1.3.3. Secondary sources

1.3.4. Primary research

1.3.5. Details of primary research

1.4. Information or Data Analysis

1.4.1. Data analysis models

1.5. Market Formulation & Validation

1.6. Model Details

1.6.1. Commodity flow analysis (Model 1)

1.6.1.1. Approach 1: Commodity flow approach

1.6.2. Volume price analysis (Model 2)

1.6.2.1. Approach 2: Volume price analysis

1.7. List of Secondary Sources

1.8. List of Primary Sources

1.9. Objectives

1.9.1. Objective 1

1.9.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.3. Competitive Insights

Chapter 3. Liquid Embolic Agent Market Variables, Trends, & Scope

3.1. Market Lineage Outlook

3.2. Market Dynamics

3.2.1. Market Driver Analysis

3.2.1.1. Rising Prevalence of Vascular Diseases

3.2.1.2. Advancements in Embolization Technologies

3.2.1.3. Growing Preference for Minimally Invasive Procedures

3.2.2. Market Restraint Analysis

3.2.2.1. High cost of agents and materials

3.2.2.2. Risk of complications and adverse events

3.2.2.3. Availability of alternative treatments

3.2.3. Market Opportunities Analysis

3.2.3.1. Technological innovations

3.2.3.2. Growing number of clinical trials

3.2.3.3. Expanding application areas

3.2.4. Market Challenge Analysis

3.2.4.1. Regulatory and approval barriers

3.3. Liquid Embolic Agent Market Analysis Tools

3.3.1. Industry Analysis – Porter’s

3.3.1.1. Bargaining power of suppliers

3.3.1.2. Bargaining power of buyers

3.3.1.3. Threat of substitutes

3.3.1.4. Threat of new entrants

3.3.1.5. Competitive rivalry

3.3.2. PESTEL Analysis

3.3.2.1. Political & Legal Landscape

3.3.2.2. Economic and Social Landscape

3.3.2.3. Technological landscape

Chapter 4. Liquid Embolic Agent Market: Product Type Estimates & Trend Analysis

4.1. Segment Dashboard

4.2. Global Liquid Embolic Agent Market Movement Analysis

4.3. Global Liquid Embolic Agent Market Size & Trend Analysis, by Product Type, 2021 to 2033 (USD Million)

4.4. Ethylene Vinyl Alcohol Copolymer (EVOH)

4.4.1. Ethylene Vinyl Alcohol Copolymer (EVOH) Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

4.5. Cyanoacrylates

4.5.1. Cyanoacrylates Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

4.5.1.1. N-BCA (n-Butyl Cyanoacrylate)

4.5.1.1.1. N-BCA (n-Butyl Cyanoacrylate) Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

4.5.1.2. N-HCA (n-Hexyl Cyanoacrylate)

4.5.1.2.1. N-HCA (n-Hexyl Cyanoacrylate) Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

4.6. Others

4.6.1. Others Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

Chapter 5. Liquid Embolic Agent Market: Application Estimates & Trend Analysis

5.1. Segment Dashboard

5.2. Global Liquid Embolic Agent Market Movement Analysis

5.3. Global Liquid Embolic Agent Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)

5.4. Arteriovenous Malformations (AVM)

5.4.1. Arteriovenous Malformations (AVM) Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

5.5. Hypervascular Tumors

5.5.1. Hypervascular Tumors Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

5.6. Peripheral Vasculature Hemorrhage

5.6.1. Peripheral Vasculature Hemorrhage Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

5.7. Others

5.7.1. Others Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

Chapter 6. Liquid Embolic Agent Market: End Use Estimates & Trend Analysis

6.1. Segment Dashboard

6.2. Global Liquid Embolic Agent Market Movement Analysis

6.3. Global Liquid Embolic Agent Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)

6.4. Hospitals

6.4.1. Hospitals Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

6.5. Specialty Clinics

6.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

6.6. Ambulatory Surgical Centers (ASCs)

6.6.1. Ambulatory Surgical Centers (ASCs) Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

6.7. Others

6.7.1. Others Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)

Chapter 7. Liquid Embolic Agent Market: Regional Estimates & Trend Analysis By Product Type, By Application, By End Use

7.1. Regional Dashboard

7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033

7.3. North America

7.3.1. North America Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.3.2. U.S.

7.3.2.1. Key Country Dynamics

7.3.2.2. Competitive Scenario

7.3.2.3. Regulatory Scenario

7.3.2.4. Reimbursement Scenario

7.3.2.5. U.S. Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.3.3. Canada

7.3.3.1. Key Country Dynamics

7.3.3.2. Competitive Scenario

7.3.3.3. Regulatory Scenario

7.3.3.4. Reimbursement Scenario

7.3.3.5. Canada Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.3.4. Mexico

7.3.4.1. Key Country Dynamics

7.3.4.2. Competitive Scenario

7.3.4.3. Regulatory Scenario

7.3.4.4. Reimbursement Scenario

7.3.4.5. Mexico Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.4. Europe

7.4.1. Europe Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.4.2. UK

7.4.2.1. Key Country Dynamics

7.4.2.2. Competitive Scenario

7.4.2.3. Regulatory Scenario

7.4.2.4. Reimbursement Scenario

7.4.2.5. UK Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.4.3. Germany

7.4.3.1. Key Country Dynamics

7.4.3.2. Competitive Scenario

7.4.3.3. Regulatory Scenario

7.4.3.4. Reimbursement Scenario

7.4.3.5. Germany Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.4.4. France

7.4.4.1. Key Country Dynamics

7.4.4.2. Competitive Scenario

7.4.4.3. Regulatory Scenario

7.4.4.4. Reimbursement Scenario

7.4.4.5. France Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.4.5. Italy

7.4.5.1. Key Country Dynamics

7.4.5.2. Competitive Scenario

7.4.5.3. Regulatory Scenario

7.4.5.4. Reimbursement Scenario

7.4.5.5. Italy Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.4.6. Spain

7.4.6.1. Key Country Dynamics

7.4.6.2. Competitive Scenario

7.4.6.3. Regulatory Scenario

7.4.6.4. Reimbursement Scenario

7.4.6.5. Spain Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.4.7. Denmark

7.4.7.1. Key Country Dynamics

7.4.7.2. Competitive Scenario

7.4.7.3. Regulatory Scenario

7.4.7.4. Reimbursement Scenario

7.4.7.5. Denmark Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.4.8. Sweden

7.4.8.1. Key Country Dynamics

7.4.8.2. Competitive Scenario

7.4.8.3. Regulatory Scenario

7.4.8.4. Reimbursement Scenario

7.4.8.5. Sweden Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.4.9. Norway

7.4.9.1. Key Country Dynamics

7.4.9.2. Competitive Scenario

7.4.9.3. Regulatory Scenario

7.4.9.4. Reimbursement Scenario

7.4.9.5. Norway Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.5. Asia Pacific

7.5.1. Asia Pacific Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.5.2. Japan

7.5.2.1. Key Country Dynamics

7.5.2.2. Competitive Scenario

7.5.2.3. Regulatory Scenario

7.5.2.4. Reimbursement Scenario

7.5.2.5. Japan Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.5.3. China

7.5.3.1. Key Country Dynamics

7.5.3.2. Competitive Scenario

7.5.3.3. Regulatory Scenario

7.5.3.4. Reimbursement Scenario

7.5.3.5. China Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.5.4. India

7.5.4.1. Key Country Dynamics

7.5.4.2. Competitive Scenario

7.5.4.3. Regulatory Scenario

7.5.4.4. Reimbursement Scenario

7.5.4.5. India Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.5.5. South Korea

7.5.5.1. Key Country Dynamics

7.5.5.2. Competitive Scenario

7.5.5.3. Regulatory Scenario

7.5.5.4. Reimbursement Scenario

7.5.5.5. South Korea Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.5.6. Australia

7.5.6.1. Key Country Dynamics

7.5.6.2. Competitive Scenario

7.5.6.3. Regulatory Scenario

7.5.6.4. Reimbursement Scenario

7.5.6.5. Australia Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.5.7. Thailand

7.5.7.1. Key Country Dynamics

7.5.7.2. Competitive Scenario

7.5.7.3. Regulatory Scenario

7.5.7.4. Reimbursement Scenario

7.5.7.5. Thailand Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.6. Latin America

7.6.1. Latin America Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.6.2. Brazil

7.6.2.1. Key Country Dynamics

7.6.2.2. Competitive Scenario

7.6.2.3. Regulatory Scenario

7.6.2.4. Reimbursement Scenario

7.6.2.5. Brazil Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.6.3. Argentina

7.6.3.1. Key Country Dynamics

7.6.3.2. Competitive Scenario

7.6.3.3. Regulatory Scenario

7.6.3.4. Reimbursement Scenario

7.6.3.5. Argentina Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.7. Middle East & Africa

7.7.1. Middle East & Africa Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.7.2. South Africa

7.7.2.1. Key Country Dynamics

7.7.2.2. Competitive Scenario

7.7.2.3. Regulatory Scenario

7.7.2.4. Reimbursement Scenario

7.7.2.5. South Africa Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.7.3. Saudi Arabia

7.7.3.1. Key Country Dynamics

7.7.3.2. Competitive Scenario

7.7.3.3. Regulatory Scenario

7.7.3.4. Reimbursement Scenario

7.7.3.5. Saudi Arabia Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.7.4. UAE

7.7.4.1. Key Country Dynamics

7.7.4.2. Competitive Scenario

7.7.4.3. Regulatory Scenario

7.7.4.4. Reimbursement Scenario

7.7.4.5. UAE Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.7.5. Kuwait

7.7.5.1. Key Country Dynamics

7.7.5.2. Competitive Scenario

7.7.5.3. Regulatory Scenario

7.7.5.4. Reimbursement Scenario

7.7.5.5. Kuwait Liquid Embolic Agent Market Estimates and Forecasts, 2021 – 2033 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants

8.2. Company/Competition Categorization

8.2.1. Innovators

8.3. Vendor Landscape

8.3.1. List of key distributors and channel partners

8.3.2. Key customers

8.3.3. Global Key company market share analysis, 2024

8.3.4. Johnson & Johnson

8.3.4.1. Company Overview

8.3.4.2. Financial Performance

8.3.4.3. Service Benchmarking

8.3.4.4. Strategic Initiatives

8.3.5. Medtronic

8.3.5.1. Company Overview

8.3.5.2. Financial Performance

8.3.5.3. Service Benchmarking

8.3.5.4. Strategic Initiatives

8.3.6. B. Braun SE

8.3.6.1. Company Overview

8.3.6.2. Financial Performance

8.3.6.3. Product Benchmarking

8.3.6.4. Strategic Initiatives

8.3.7. Terumo

8.3.7.1. Company Overview

8.3.7.2. Financial Performance

8.3.7.3. Product Benchmarking

8.3.7.4. Strategic Initiatives

8.3.8. Boston Scientific Corporation

8.3.8.1. Company Overview

8.3.8.2. Financial Performance

8.3.8.3. Product Benchmarking

8.3.8.4. Strategic Initiatives

8.3.9. Balt

8.3.9.1. Company Overview

8.3.9.2. Financial Performance

8.3.9.3. Product Benchmarking

8.3.9.4. Strategic Initiatives

8.3.10. BlackSwan Vascular, Inc.

8.3.10.1. Company Overview

8.3.10.2. Financial Performance

8.3.10.3. Product Benchmarking

8.3.10.4. Strategic Initiatives

8.3.11. INVAMED

8.3.11.1. Company Overview

8.3.11.2. Financial Performance

8.3.11.3. Product Benchmarking

8.3.11.4. Strategic Initiatives

8.3.12. Meril

8.3.12.1. Company Overview

8.3.12.2. Financial Performance

8.3.12.3. Product Benchmarking

8.3.12.4. Strategic Initiatives

8.3.13. Gem srl

8.3.13.1. Company Overview

8.3.13.2. Financial Performance

8.3.13.3. Product Benchmarking

8.3.13.4. Strategic Initiatives

8.4. Heat Map Analysis/ Company Market Position Analysis

8.5. Estimated Company Market Share Analysis, 2024

8.6. List of Other Key Market Players

List of Tables

Table 1. List of Secondary Sources

Table 2. List of Abbreviations

Table 3. Global Liquid Embolic Agent Market, by Region, 2021 – 2033 (USD Million)

Table 4. Global Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 5. Global Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 6. Global Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 7. North America Liquid Embolic Agent Market, by Country, 2021 – 2033 (USD Million)

Table 8. North America Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 9. North America Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 10. North America Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 11. U.S. Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 12. U.S. Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 13. U.S. Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 14. Canada Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 15. Canada Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 16. Canada Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 17. Europe Liquid Embolic Agent Market, by Country, 2021 – 2033 (USD Million)

Table 18. Europe Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 19. Europe Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 20. Europe Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 21. Germany Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 22. Germany Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 23. Germany Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 24. UK Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 25. UK Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 26. UK Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 27. France Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 28. France Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 29. France Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 30. Italy Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 31. Italy Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 32. Italy Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 33. Spain Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 34. Spain Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 35. Spain Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 36. Denmark Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 37. Denmark Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 38. Denmark Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 39. Sweden Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 40. Sweden Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 41. Sweden Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 42. Norway Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 43. Norway Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 44. Norway Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 45. Asia Pacific Liquid Embolic Agent Market, by Country, 2021 – 2033 (USD Million)

Table 46. Asia Pacific Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 47. Asia Pacific Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 48. Asia Pacific Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 49. China Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 50. China Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 51. China Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 52. Japan Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 53. Japan Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 54. Japan Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 55. India Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 56. India Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 57. India Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 58. South Korea Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 59. South Korea Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 60. South Korea Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 61. Australia Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 62. Australia Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 63. Australia Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 64. Thailand Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 65. Thailand Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 66. Thailand Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 67. Latin America Liquid Embolic Agent Market, by Country, 2021 – 2033 (USD Million)

Table 68. Latin America Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 69. Latin America Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 70. Latin America Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 71. Brazil Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 72. Brazil Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 73. Brazil Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 74. Mexico Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 75. Mexico Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 76. Mexico Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 77. Argentina Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 78. Argentina Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 79. Argentina Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 80. Middle East & Africa Liquid Embolic Agent Market, by Country, 2021 – 2033 (USD Million)

Table 81. Middle East & Africa Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 82. Middle East & Africa Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 83. Middle East & Africa Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 84. South Africa Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 85. South Africa Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 86. South Africa Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 87. Saudi Arabia Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 88. Saudi Arabia Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 89. Saudi Arabia Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 90. UAE Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 91. UAE Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 92. UAE Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 93. Kuwait Liquid Embolic Agent Market, by Product Type, 2021 – 2033 (USD Million)

Table 94. Kuwait Liquid Embolic Agent Market, by Application, 2021 – 2033 (USD Million)

Table 95. Kuwait Liquid Embolic Agent Market, by End Use, 2021 – 2033 (USD Million)

Table 96. Participant’s Overview

Table 97. Financial Performance

Table 98. Product Benchmarking

Table 99. Strategic Initiatives

List of Figures

Fig. 1 Information Procurement

Fig. 2 Primary Research Pattern

Fig. 3 Market Research Approaches

Fig. 4 Value Chain-Based Sizing & Forecasting

Fig. 5 Market Formulation & Validation

Fig. 6 Liquid Embolic Agent Market, Market Segmentation

Fig. 7 Market Driver Analysis (Current & Future Impact)

Fig. 8 Market Restraint Analysis (Current & Future Impact)

Fig. 9 Market Opportunity Analysis (Current & Future Impact)

Fig. 10 Market Challenge Analysis (Current & Future Impact)

Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)

Fig. 12 Porter’s Five Forces Analysis

Fig. 13 Regional Marketplace: Key Takeaways

Fig. 14 Global Liquid Embolic Agent Market, for Ethylene Vinyl Alcohol Copolymer (EVOH), 2021 – 2033 (USD Million)

Fig. 15 Global Liquid Embolic Agent Market, for Cyanoacrylates, 2021 – 2033 (USD Million)

Fig. 16 Global Liquid Embolic Agent Market, for N-BCA (n-Butyl Cyanoacrylate), 2021 – 2033 (USD Million)

Fig. 17 Global Liquid Embolic Agent Market, for N-HCA (n-Hexyl Cyanoacrylate), 2021 – 2033 (USD Million)

Fig. 18 Global Liquid Embolic Agent Market, for Others, 2021 – 2033 (USD Million)

Fig. 19 Global Liquid Embolic Agent Market, for Arteriovenous Malformations (AVM), 2021 – 2033 (USD Million)

Fig. 20 Global Liquid Embolic Agent Market, for Hypervascular Tumors, 2021 – 2033 (USD Million)

Fig. 21 Global Liquid Embolic Agent Market, for Peripheral Vasculature Hemorrhage, 2021 – 2033 (USD Million)

Fig. 22 Global Liquid Embolic Agent Market, for Others, 2021 – 2033 (USD Million)

Fig. 23 Global Liquid Embolic Agent Market, for Hospitals, 2021 – 2033 (USD Million)

Fig. 24 Global Liquid Embolic Agent Market, for Specialty Clinics, 2021 – 2033 (USD Million)

Fig. 25 Global Liquid Embolic Agent Market, for Ambulatory Surgical Centers (ASCs), 2021 – 2033 (USD Million)

Fig. 26 Global Liquid Embolic Agent Market, for Others, 2021 – 2033 (USD Million)

Fig. 27 Regional Outlook, 2024 & 2033

Fig. 28 North America Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 29 U.S. Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 30 Canada Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 31 Europe Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 32 Germany Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 33 UK Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 34 France Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 35 Italy Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 36 Spain Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 37 Denmark Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 38 Sweden Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 39 Norway Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 40 Asia Pacific Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 41 Japan Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 42 China Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 43 India Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 44 Australia Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 45 South Korea Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 46 Thailand Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 47 Latin America Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 48 Brazil Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 49 Mexico Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 50 Argentina Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 51 Middle East and Africa Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 52 South Africa Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 53 Saudi Arabia Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 54 UAE Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Fig. 55 Kuwait Liquid Embolic Agent Market, 2021 – 2033 (USD Million)

Grand View Researchについて

Grand View Research（グランドビューリサーチ） はインドと米国を拠点とする市場調査およびコンサルティング会社です。世界中主要 25ヵ国・ 46 業界に関する豊富なデータベースを活用した市場情報は世界の企業団体に活用・引用されています。日本からのレポートのご注文・ご購入相談はお気軽にお問い合わせください。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ 1

ライセンスタイプ 2

ライセンスタイプ 3

ライセンスタイプ 4

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス（インディビジュアルライセンス）
    • 1名のみレポートファイル（印刷不可）をご利用いただけます。
  • チームライセンス
    • 同一企業（関連会社除く）内5名まで共有可能です。印刷可能な電子ファイルをご提供いたします。
  • コーポレートライセンス
    • 同一企業および関連会社内で人数無制限で共有可能です。印刷可能な電子ファイルをご提供いたします。
    • 「関連会社」の範囲についてはお気軽にお問い合わせください。
• 納品形態
  • オンラインダウンロード
• 納期
  • ご注文後1～7営業日　※レポートにより異なります。

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

最新出版レポート

• ARクラウド市場規模、成長と動向分析レポート 2025-2033年
• ノーコードAIプラットフォーム市場規模、成長と動向分析レポート 2025-2033年
• 量子コンピューティングにおけるAI最適化市場規模、成長と動向分析レポート 2025-2033年
• ワイヤレス状態監視システム市場規模、成長と動向分析レポート 2025-2033年
• ゲームストリーミング市場規模、成長と動向分析レポート 2025-2033年

出版レポート一覧